Novel treatment options in stage I non-small-cell lung cancer.

about

High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.The Function and Mechanism of Long Non-coding RNA-ATB in Cancers.

P2860

Q38729414-4EF8968E-7DE8-4FBA-A5B9-30A8901AC7F9 Q52564659-9910C73F-21B7-452E-9ACD-FF886BF546DE

P2860

Novel treatment options in stage I non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q38220335

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Novel treatment options in stage I non-small-cell lung cancer.

@en

type

Item

label

Novel treatment options in stage I non-small-cell lung cancer.

@en

prefLabel

Novel treatment options in stage I non-small-cell lung cancer.

@en

P1476

Novel treatment options in stage I non-small-cell lung cancer.

@en

P2093

Frederik Vandaele

http://www.w3.org/2001/XMLSchema#string

Jan P van Meerbeeck

http://www.w3.org/2001/XMLSchema#string

Patrick Lauwers

http://www.w3.org/2001/XMLSchema#string

Svitlana Tarasevych

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review

Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification

Should randomized clinical trials be required for proton radiotherapy?

Image-guided thermal ablation of lung malignancies.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Results of the two incidence screenings in the National Lung Screening Trial.

When to wait for more evidence? Real options analysis in proton therapy.

P304

1007-1020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2014.929500

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24930519

http://www.w3.org/2001/XMLSchema#string

Novel treatment options in stage I non-small-cell lung cancer.

about

P2860

P2860

Novel treatment options in stage I non-small-cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698